Literature DB >> 17032884

Normal-appearing white matter changes vary with distance to lesions in multiple sclerosis.

H Vrenken1, J J G Geurts, D L Knol, C H Polman, J A Castelijns, P J W Pouwels, F Barkhof.   

Abstract

BACKGROUND AND
PURPOSE: Multiple sclerosis (MS) disease processes in normal-appearing white matter (NAWM) may be different close to MR-visible lesions than farther from these lesions. We aimed to investigate the relationship of NAWM changes to the distance to the lesions.
METHODS: We measured B(1)-corrected T1 and magnetization transfer ratio (MTR) maps in 63 patients with MS (11 primary progressive, 34 relapsing-remitting, 18 secondary progressive). We used histogram analyses to assess the global properties of lesions, of 4 consecutive 1-mm pixel layers of NAWM around the lesions, and of distant NAWM located at least 4-mm from lesions in all directions. In 22 healthy controls, we measured white matter MTR and T1 histograms. Histogram parameters were statistically analyzed by using a linear mixed model.
RESULTS: The first and second NAWM pixel layers around the lesions had a significantly lower MTR histogram peak position than distant NAWM, whereas T1 histogram peak position was similar between all types of NAWM. Furthermore, MTR histograms of distant NAWM were statistically indistinguishable from those of control white matter, whereas T1 histograms of distant NAWM had significantly decreased peak height for relapsing-remitting MS and secondary progressive MS and significantly increased peak position for secondary progressive MS.
CONCLUSION: Our results may suggest that axonal damage and demyelination in NAWM mainly arise as a secondary result of visible lesions, with the largest effect close to these lesions. NAWM disease farther from the lesions may be mainly characterized by subtle blood-brain barrier damage, with leakage of fibrinogen into the parenchyma and microplaque formation, processes that are detected with T1 but not with MTR.

Entities:  

Mesh:

Year:  2006        PMID: 17032884      PMCID: PMC7977884     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  44 in total

1.  Accurate determination of spin-density and T1 in the presence of RF-field inhomogeneities and flip-angle miscalibration.

Authors:  R Venkatesan; W Lin; E M Haacke
Journal:  Magn Reson Med       Date:  1998-10       Impact factor: 4.668

2.  Correlates of MS disability assessed in vivo using aggregates of MR quantities.

Authors:  C Mainero; N De Stefano; G Iannucci; M P Sormani; L Guidi; A Federico; M L Bartolozzi; G Comi; M Filippi
Journal:  Neurology       Date:  2001-05-22       Impact factor: 9.910

3.  Axonal transection in the lesions of multiple sclerosis.

Authors:  B D Trapp; J Peterson; R M Ransohoff; R Rudick; S Mörk; L Bö
Journal:  N Engl J Med       Date:  1998-01-29       Impact factor: 91.245

4.  White matter and lesion T1 relaxation times increase in parallel and correlate with disability in multiple sclerosis.

Authors:  A Parry; S Clare; M Jenkinson; S Smith; J Palace; P M Matthews
Journal:  J Neurol       Date:  2002-09       Impact factor: 4.849

5.  The spinal cord in multiple sclerosis: relationship of high-spatial-resolution quantitative MR imaging findings to histopathologic results.

Authors:  Joseph C J Bot; Erwin L A Blezer; Wouter Kamphorst; Geert J Lycklama A Nijeholt; Herman J Ader; Jonas A Castelijns; Klaas Nicolay Ig; Elisabeth Bergers; Rivka Ravid; Chris Polman; Frederik Barkhof
Journal:  Radiology       Date:  2004-09-22       Impact factor: 11.105

6.  Correlation of volumetric magnetization transfer imaging with clinical data in MS.

Authors:  M A van Buchem; R I Grossman; C Armstrong; M Polansky; Y Miki; F H Heyning; M P Boncoeur-Martel; L Wei; J K Udupa; M Grossman; D L Kolson; J C McGowan
Journal:  Neurology       Date:  1998-06       Impact factor: 9.910

Review 7.  Magnetic resonance studies of abnormalities in the normal appearing white matter and grey matter in multiple sclerosis.

Authors:  D H Miller; A J Thompson; M Filippi
Journal:  J Neurol       Date:  2003-12       Impact factor: 4.849

8.  Assessment and correction of B1-induced errors in magnetization transfer ratio measurements.

Authors:  Stefan Ropele; Massimo Filippi; Paola Valsasina; Tijmen Korteweg; Frederik Barkhof; Paul S Tofts; Rebecca Samson; David H Miller; Franz Fazekas
Journal:  Magn Reson Med       Date:  2005-01       Impact factor: 4.668

9.  The relationship between lesion and normal appearing brain tissue abnormalities in early relapsing remitting multiple sclerosis.

Authors:  Colette M Griffin; Declan T Chard; Geoff J M Parker; Gareth J Barker; Alan J Thompson; David H Miller
Journal:  J Neurol       Date:  2002-02       Impact factor: 4.849

10.  Axonal loss in multiple sclerosis lesions: magnetic resonance imaging insights into substrates of disability.

Authors:  J H van Waesberghe; W Kamphorst; C J De Groot; M A van Walderveen; J A Castelijns; R Ravid; G J Lycklama à Nijeholt; P van der Valk; C H Polman; A J Thompson; F Barkhof
Journal:  Ann Neurol       Date:  1999-11       Impact factor: 10.422

View more
  27 in total

1.  Multiple sclerosis normal-appearing white matter: pathology-imaging correlations.

Authors:  Natalia M Moll; Anna M Rietsch; Smitha Thomas; Amy J Ransohoff; Jar-Chi Lee; Robert Fox; Ansi Chang; Richard M Ransohoff; Elizabeth Fisher
Journal:  Ann Neurol       Date:  2011-11       Impact factor: 10.422

2.  Short-term stability of T1 and T2 relaxation measures in multiple sclerosis normal appearing white matter.

Authors:  Alice L W Liang; Irene M Vavasour; Burkhard Mädler; Anthony L Traboulsee; Donna J Lang; David K B Li; Alex L MacKay; Cornelia Laule
Journal:  J Neurol       Date:  2011-11-26       Impact factor: 4.849

Review 3.  Quantitative MR Imaging of Brain Tissue and Brain Pathologies.

Authors:  E Hattingen; A Jurcoane; M Nelles; A Müller; U Nöth; B Mädler; P Mürtz; R Deichmann; H H Schild
Journal:  Clin Neuroradiol       Date:  2015-07-30       Impact factor: 3.649

4.  Fiber density index in the evaluation of the spinal cord in patients with multiple sclerosis.

Authors:  M Ukmar; A Montalbano; E Makuc; I Specogna; A Bratina; R Longo; M A Cova
Journal:  Radiol Med       Date:  2012-06-28       Impact factor: 3.469

Review 5.  MRI in multiple sclerosis: what's inside the toolbox?

Authors:  Mohit Neema; James Stankiewicz; Ashish Arora; Zachary D Guss; Rohit Bakshi
Journal:  Neurotherapeutics       Date:  2007-10       Impact factor: 7.620

6.  Magnetization transfer ratio in lesions rather than normal-appearing brain relates to disability in patients with multiple sclerosis.

Authors:  Michael Amann; Athina Papadopoulou; Michaela Andelova; Stefano Magon; Nicole Mueller-Lenke; Yvonne Naegelin; Christoph Stippich; Ernst Wilhelm Radue; Oliver Bieri; Ludwig Kappos; Till Sprenger
Journal:  J Neurol       Date:  2015-06-05       Impact factor: 4.849

Review 7.  Assessing Repair in Multiple Sclerosis: Outcomes for Phase II Clinical Trials.

Authors:  Maria Pia Sormani; Matteo Pardini
Journal:  Neurotherapeutics       Date:  2017-10       Impact factor: 7.620

8.  Magnetization transfer ratio measures in normal-appearing white matter show periventricular gradient abnormalities in multiple sclerosis.

Authors:  Zheng Liu; Matteo Pardini; Özgür Yaldizli; Varun Sethi; Nils Muhlert; Claudia A M Wheeler-Kingshott; Rebecca S Samson; David H Miller; Declan T Chard
Journal:  Brain       Date:  2015-03-29       Impact factor: 13.501

9.  Beyond focal cortical lesions in MS: An in vivo quantitative and spatial imaging study at 7T.

Authors:  Céline Louapre; Sindhuja T Govindarajan; Costanza Giannì; Christian Langkammer; Jacob A Sloane; Revere P Kinkel; Caterina Mainero
Journal:  Neurology       Date:  2015-10-14       Impact factor: 9.910

10.  A comparative assessment of cerebral white matter by magnetization transfer imaging in early- and adult-onset multiple sclerosis patients matched for disease duration.

Authors:  Kader K Oguz; Asli Kurne; Aysegul Oz Aksu; Aslihan Taskiran; Erdem Karabulut; Rana Karabudak
Journal:  J Neurol       Date:  2010-03-11       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.